Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 8
- +1 vs. Q1 2021
- Portfolio value
- $501.9M
- +$65.6M (+15.0%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CPNGCoupang, Inc. | CL A | 4,564,571 | $190.9M | 38.0% | 00.0% | Unchanged | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,865,610 | $81.4M | 16.2% | +7,865,610 | New | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $77.8M | 15.5% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,842,077 | $50.6M | 10.1% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $47.6M | 9.5% | 00.0% | Unchanged | History |
| YEXTYext, Inc. | COM | 2,146,785 | $30.7M | 6.1% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $17.8M | 3.6% | 00.0% | Unchanged | History |
| UBXUnity Biotechnology, Inc. | COM | 1,094,998 | $5.08M | 1.0% | 00.0% | Unchanged | History |